Drug & medication recalls Moderate risk

Estradiol USP 99 recalled over sterility concerns

Recall date
October 9, 2015
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Qualgen recalls Estradiol USP 99.5%, .5% Stearic Acid NF Pellets, 3 mL, one-count vials, 6 mg (NDC 69761-006-01),10 mg (NDC 69761-010-0…
Recall number
D-0386-2016
FDA classification
Class II
Brand / firm
Qualgen
Sold / distributed
Nationwide

Why it was recalled

Lack of Assurance of Sterility: The firm is recalling all sterile preparations within expiry due to deficient practices which may have an impact on sterility assurance.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Estradiol USP 99.5%, .5% Stearic Acid NF Pellets, 3 mL, one-count vials, 6 mg (NDC 69761-006-01),10 mg (NDC 69761-010-01),12.5 mg (NDC 69761-012-01), 15 mg (NDC 69761-015-01),18 mg (NDC 69761-018-01),20 mg (NDC 69761-020-01), 22 mg (NDC 69761-022-01), 25 mg (NDC 69761-025-01), Rx only, Compounded by Qualgen, Edmond, Oklahoma 73013

Get recall alerts

Free email alert whenever Qualgen has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Qualgen